Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2021
November 15, 2021 08:30 ET
|
Summit Therapeutics Inc.
Cambridge, Massachusetts, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on...
Dolbey Adds Denial Management Module to Their Healthcare Revenue Cycle Suite
October 25, 2021 10:15 ET
|
Dolbey
CONCORD, Ohio, Oct. 25, 2021 (GLOBE NEWSWIRE) -- When healthcare providers submit a billing claim to a payor and the payor denies the claim, a set of events must occur which, for many, is...
Summit Therapeutics Presents Further Breakthrough Insights Surrounding the Novel Mechanism of Action for its Investigational Drug Ridinilazole During IDWeek 2021
September 30, 2021 09:00 ET
|
Summit Therapeutics Inc.
Cambridge, Massachusetts, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or the “Company”) is today displaying an important ePoster at IDWeek 2021. IDWeek is...
Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2021
August 11, 2021 08:01 ET
|
Summit Therapeutics Inc.
Cambridge, Massachusetts, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on...
Summit Therapeutics Provides Update on Ri-CoDIFy Trials
August 11, 2021 08:00 ET
|
Summit Therapeutics Inc.
Cambridge, Massachusetts, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Based on a thorough review of the design and enrollment status of two ongoing blinded Phase III Ri-CoDIFy trials, Summit Therapeutics...
Summit Therapeutics to Present Breakthrough Research Updates at the 31st Annual ECCMID Conference, including a Top-Rated ePoster
July 01, 2021 08:00 ET
|
Summit Therapeutics Inc.
Cambridge, MA, July 01, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (the “Company”) today announced that members of our scientific team will present breakthrough research...
Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2020
March 17, 2021 07:00 ET
|
Summit Therapeutics plc
Summit Therapeutics Inc.(‘Summit’ or the ‘Company’) Cambridge, MA, March 17, 2021 - Summit Therapeutics Inc. (NASDAQ: SMMT) today reports its financial results and provides an update on...
“CRM Is Not Enough,” Say Leading Independent Software Companies
January 16, 2020 05:00 ET
|
Segment
Over 200 companies unite to launch The Platform of Independents, a group pledging to liberate data from the limitations of traditional CRM suites and allow businesses to build customized technology...
Segment Achieves AWS Retail Competency Status
January 13, 2020 16:30 ET
|
Segment
Customer Data Infrastructure Company is Recognized for its Proven Success Helping Retailers Digitally Transform and Deliver Personalization at Massive Scale SAN FRANCISCO, Jan. 13, 2020 (GLOBE...
Segment Named Among The Fastest Growing Companies in North America on Deloitte’s 2019 Technology Fast 500™ For Second Consecutive Year
November 07, 2019 15:30 ET
|
Segment
SAN FRANCISCO, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Segment, the customer data infrastructure company, today announced it ranked No. 323 on Deloitte’s Technology Fast 500™, a list of the 500 fastest...